Professional Documents
Culture Documents
Abstract
Introduction: The placenta is an organ that is attached to the uterine wall and connects the fetus with the mother through
the umbilical cord. The placenta is said to be retained when it is not expelled out even half an hour after the birth of the
baby. The study aimed to evaluate the retention of the placenta. Methods: This was a cross-sectional study was
conducted at the Department of Obstetrics & Gynecology, Faridpur Medical College Hospital, Faridpur from June 2016
to November 2016. The sample was taken purposively and the sample size was 110. Patients were diagnosed with a case
of 'retained placenta' through proper history, and clinical examination. Written informed consent was taken from every
patient or their relatives. The information was collected in a preformed data collection sheet. Observation and results of
the study and statistical analysis were presented in tables. Data were analyzed by using the computer-based program
Statistical Package for Social Science (SPSS) software for windows. Result: Out of 110 study subjects about 58.18%
were found in the age group of 21-30 years and 20% were found in the age group of 20 years. The age of the patients
ranges from 18 to 40 years. Among 110 study subjects, 64.55% were from lower socioeconomic status, 27.27% were
from middle socioeconomic status and only 8.18% belonged to affluent socioeconomic status. The majority (74.54%) of
cases were delivered at home and 25.46% of cases were delivered at different levels of hospitals (among them 1.82% of
cases occurred in the institute where the study was done). Among them 20% were para- 1, 54.54% were para-2-4 and
25.46% of respondents were para ≥ 5. The majority (60%) of study subjects were admitted between 3 to 8 hours after
developing retained placenta, followed by 18.19% who came within 2 hours. Regarding the clinical presentation, 69.09%
of study subjects presented with anemia of varying degrees, 24.53% presented with shock, 5.45% presented with sepsis,
and only 0.93% (one patient) presented with acute renal failure. Concerning predisposing factors of retained placenta,
25.46% of study subjects were grand multipara, 11.82% had H/O MR or D & C, 10.90% with prolonged labor, 10.90%
respondents had IUD, 10% with past H/O retained placenta, 8.20% had preterm labor, 2.72% had H/O LUCS/ other
uterine surgery and 20% were without any predisposing factors. Among the respondents, 27.27% of study subjects
presented with genital tract trauma, 5.45% with sepsis, 5.45% with acute renal failure, 0.91% with DIC, 0.91% with
uterine prolapse 64.55% with no associated conditions/complications. Among the total study population, 58.18% of
retained placenta cases required manual removal under G/A, and 41.82% were managed by manual removal of the
placenta under deep sedation. Out of 110 respondents, 21.82% of cases of retained placenta did not require any blood
transfusion, 58.18% received 1-2 units and 20% received 3 or more units of blood transfusion. During management,
13.63% of study subjects developed uterine atony, 0.91% developed uterine inversion, 2.73% were complicated by
uterine perforation, 0.91% were complicated by anesthetic hazard; 81.82% had no complication during management. Out
of 110, 18.18% of study subjects experienced various complications. Among them 9.10% were managed by intrauterine
balloon tamponade,2.73% required hysterectomy, and 6.37% were managed by other measures. 70% of respondents
stayed in the hospital for 1-3 days, 26.36% for 4 to 7 days, and 3.64% stayed more than 7 days before discharge.
Regarding the outcome of retained placenta among study subjects, 80.91% improved and discharged, 10% had severe
anemia and required subsequent blood transfusion, 6.36% developed an infection, 0.91% developed acute renal failure
and 2 patients died (one due to DIC and another patient due to irreversible shock). Conclusion: The retained placenta is
an obstetric emergency. Rapid recognition and treatments are essential because heavy blood loss with coagulation
Citation: Alam, S, Chowdhury, A. H, Khan, S. A, Saha, S (2022). Evaluation of Retained Placenta: A Study in a District 455
Hospital. Sch Int J Obstet Gynec, 5(10): 455-461.
Alam, S et al; Sch Int J Obstet Gynec, Oct. 2022; 5(10): 455-461
problems remains the lethal factor in this disease. Rapid control of hemorrhage should be the first initiative. Active
management of the third stage of labor lowers the danger by a significant percentage.
Keywords: Placenta, Shock, AMTSL, Labor, Anemia.
Copyright © 2022 The Author(s): This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International
License (CC BY-NC 4.0) which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original
author and source are credited.
© 2022 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 457
Alam, S et al; Sch Int J Obstet Gynec, Oct. 2022; 5(10): 455-461
Table 3: Distribution of study subjects according to the place of delivery, (N=110)
Place of delivery N %
Home 82 74.54
Thana health complex 10 9.09
MCH 07 6.37
Private clinic 06 5.45
District hospital 03 2.73
Faridpur Medical College Hospital 02 1.82
Total 110 100
Table 5: Time interval between the retained placenta and hospital admission, (N=110)
Time (in an hour) N %
0-2 20 18.19
3-8 66 60
9-24 18 16.36
>24 06 5.45
Total 110 100
Table 6: Distribution of study subjects according to the clinical presentation of retained placenta, (N=110)
Clinical presentation N %
Anemia 76 69.09
Shock 27 24.53
Sepsis 06 5.45
Acute renal failure 01 0.93
Total 110 100
© 2022 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 458
Alam, S et al; Sch Int J Obstet Gynec, Oct. 2022; 5(10): 455-461
Table 9: Distribution of respondents by mode of management of retained placenta (N=110)
Mode of management N %
Manual removal under G/A 64 58.18
Manual removal under deep sedation 46 41.82
Total 110 100
Table 10: Distribution of study subjects according to the necessity of blood transfusion (N=110)
Blood transfusion N %
Not required 24 21.82
Required 86 78.18
1-2 unit 64 58.18
≥3 unit 22 20
Table 11: Distribution of respondents by a complication during the management of retained placenta (N=110)
Complication during management N %
Uterine atony 15 13.63
Uterine perforation 3 2.73
Uterine inversion 1 0.91
Anesthetic hazard 1 0.91
No complications 90 81.82
Total 110 100
Table 12: Distribution of respondents by management of complications of treatment of retained placenta (N=110)
Management of complications N %
Intrauterine balloon tamponade 10 9.10
Hysterectomy 3 2.73
Others 7 6.37
No management required 90 81.82
Total 110 100
Table 13: Distribution of subjects according to the length of hospital stay for retention of the placenta, (N=110)
Duration of hospital stay N %
24 hours to 3 days 77 70
4 days to 7 days 29 26.36
>7 days 4 3.64
Total 110 100
© 2022 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 459
Alam, S et al; Sch Int J Obstet Gynec, Oct. 2022; 5(10): 455-461
showed that 74.54% of study subjects were para 1 to 4. 7 days, and only 3.64% had to stay more than 7 days.
The percentage of grand multipara women (25.46%) in The result is consistent with the study done by other
this study is higher than that seen in the other two two authors [15, 16]. Findings also showed that 80.91%
studies [19, 17] but similar to that reported by another of the study subjects recovered more or less completely
author [20]. Regarding the interval between hospital (including mild to moderately anemic patients); 10%
admission and development of the retained placenta, it suffered from severe anemia; 6.36% developed sepsis,
was found that most of the study subjects (60%) were and 0.91% developed acute renal failure. Unfortunately,
admitted between 3-8 hours after developing retained 2 patients died, one due to Disseminated Intravascular
placenta which is consistent with the findings of other Coagulation (DIC) and one due to irreversible shock.
studies [16-18]. Concerning the clinical presentation The result was also relatable to another study [15].
69.09% of study subjects presented with varying
degrees of anemia. Most of them were severely anemic, Limitations of The Study
24.53% presented with shock, 5.45% presented with The study was conducted in a single hospital
sepsis, and only 1 patient presented with acute renal with a small sample size. So, the results may not
failure which was quite similar to a study [15]. A study represent the whole community.
showed that 26 (36.61%) women had come in a state of
severe shock [17]. Moreover, the same picture was seen CONCLUSION
in a study in another medical college hospital where The retained placenta is an obstetric
71.65% of patients were anemic, which was quite emergency. Rapid recognition and treatments are
understandable in the present study [21]. Regarding the essential because heavy blood loss with coagulation
predisposing factors of retained placenta among the problems remains the lethal factor in this disease.
respondents of this study, 25.46% were grand Mismanagement of 3rd stage of labor is one of the major
multipara, 10.90% had H/O prolonged labor, 11.82% causes of uterine inertia leading to postpartum
were giving H/O MR/D&C, and 10% of respondents hemorrhage and retained placenta. Identification of the
with a history of retained placenta in the past, and risk factors for developing retained placenta during
10.90% with IUD. The results were nearly consistent antenatal care and properly conducted delivery with
with another study [15]. It was found in a study that the active management of the third stage of labor can
previous history of retained placenta and prolonged reduce the frequency of retained placenta. All the
delivery in current pregnancy were significantly related resources should be utilized for the proper training of
to retention of placenta. MR or Post delivery curettage birth attendants so that the high-risk cases can be
itself is not a cause of retained placenta, rather curettage identified at the right time and should be referred to a
and infections after MR or puerperal endometritis can well-equipped institution where blood transfusion and
be probable predisposing factors of retained placenta operative facilities are available. The evaluation of
[22]. A retrospective study showed that the recurrence retained placenta cases is necessary, as PPH is the most
of retained placenta was 32% while there was placenta common cause of maternal mortality in our country.
accreta and a H/O multiple retained placentas [23]. The maternal outcome in retained placenta cases is
Another study showed that 10% had a retained placenta inversely proportional to the time required for
in the past which was consistent with the present study treatment.
[17]. A study by another author also showed that 16%
of patients had retained placenta before [24]. Regarding RECOMMENDATION
the management of retained placenta, 58.18% of For prevention and proper management of
patients were managed by manual removal under retained placenta cases, all deliveries must be
general anesthesia and 41.82% by manual removal conducted by skilled birth attendants preferably in an
under deep sedation. The use of umbilical vein injection institution. All pregnant mothers having predisposing
of oxytocin with normal saline was not used in the factors for retained placenta must deliver in a hospital
management of patients despite some beneficial effects equipped with skilled manpower and facilities to deal
documented in the Cochrane library because of no with obstetrical emergencies including surgery and
experience with the technique [25]. The requirement for blood transfusion. A multi-center large-scale study may
transfusion was more among the patients managed by be done for a better understanding of the incidence,
manual removal under general anesthesia. In this study, predisposing factors, and management options of
86 (78.18%) patients received blood transfusion which retained placenta Price of the retained placenta can be
greatly differs from the findings of the other two extremely devastating if not managed early. Besides
studies, where the percentage was 40% and 10% other required measures, patient and patient party
respectively [22, 24]. This may be because pregnant motivation is also important, as the decisions are made
women in this country suffer more from anemia. Need by the family members in our society.
for blood was more than the amount transfused but the
patient could not afford it due to a lack of money, Funding: No funding sources
donors, and also blood in the blood bank. Regarding the
length of hospital stay by study subjects, it showed that Conflict of interest: None declared
70% stayed in the hospital for 1-3 days, 26.36% for 4 to
© 2022 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 460
Alam, S et al; Sch Int J Obstet Gynec, Oct. 2022; 5(10): 455-461
13. WHO, UNICEF, UNFPA, WORLD BANK,
Ethical approval: The study was approved by the IMPAC managing complications in pregnancy and
Institutional Ethics Committee childbirth, WHO department of reproductive health
and research, 2000; 778-779.
REFERENCES 14. Pipings, A., Hofmeyer, G. J., & Sesel, K. R.
1. Poggi Sarah, H. (2008). Postpartum Haemorrhage (1993). Umbilical vessels oxytocin for retained
and abnormal puerperium; In DeCherney Alan H, placenta, AMJ, Obstet Gynecol, 168, 793-795.
Nathan Lauren, Goodwin T. Murphy, Laufer 15. Begum, M. (2005). Clinical presentation,
Neri(editor) Current Diagnosis and treatment, predisposing factors and outcome of retained
Obstetrics & Gynaecology, 10th edition, McGraw placenta among admitted cases in DMCH
Hill, New York, 54-56, 163-172. (Dissertation), BCPS, 40-45.
2. Huppertz, B. (2008). The anatomy of the normal 16. Lima, S. (2005). The effect of oxytocin into the
placenta. Journal of clinical pathology, 61(12), umbilical vein for the management of retained
1296-1302. placenta in DMCH (Dissertation), BCPS, 48-55.
3. Takahashi, H., Tanaka, H., Osuga, Y., Miura, K., 17. Chhabra, S., & Dhorey, M. (2004). Retained
Saito, S., Sato, S., ... & Ikeda, T. (2022). Retained Placenta continues to be fatal but the frequency can
products of conception (RPOC) following delivery be reduced. Journal of Obstetrics and
without placenta previa: Which patients with Gynaecology, 24, 891-894.
RPOC show postpartum hemorrhage?. Placenta. 18. Das, S. R. (2003). Incidence and causes of retained
4. Dutta, D. C. (2011). Complications of the third placenta among the admitted cases in DMCH
stage of labor; In Text Book of Obstetrics, 7th (Dissertation), BCPS, 55-60.
edition, New Central Book Agency (PVT) Ltd., 19. Soltan, H., & Khashoggi, T. M. (1997). Retained
Calcutta, India, 28-37, 417-418. placenta and associated risk factors. Journal of
5. Daftary Shirish, N. (1990). Chakrabarty Sudip, Obstetrics and Gynaecology, 17(3), 245-247.
Abnormal labor; In Holland and Brews Manual of 20. Onwudiegwu, U., & Makinde, O. N. (1999).
Obstetrics, 6th edition; Churchill Livingstone, New Retained placenta: a cause of reproductive
Delhi, 222-224. morbidity in Nigeria. Journal of Obstetrics and
6. Orji, E., Agwu, F., Loto, O., & Olaleye, O. (2008). Gynaecology, 19(4), 355-359.
A randomized comparative study of prophylactic 21. Tuladhar, H., Dali, S. M., & Pradhanang, V.
oxytocin versus ergometrine in the third stage of (2005). Complications of home delivery: a
labor. International Journal of Gynecology & retrospective analysis. Journal of the Nepal
Obstetrics, 101(2), 129-132. Medical Association, 44(159), 87-91.
7. Andrews, C. J. (1924). Report of a case of retained 22. Titiz, H., Wallace, A., & Voaklander, D. C. (2001).
placenta, clinically placenta accreta. Journal of the Manual removal of the placenta‐a case control
American Medical Association, 82(22), 1780-1780. study. Australian and New Zealand Journal of
8. John, M., Thorp, R. (1992). Bruce Councell, David Obstetrics and Gynaecology, 41(1), 41-44.
A Standridge, and Helen H Wiest. Antepartum 23. Van Beekhuizen, H. J., & Vierhout, M. E. (1994).
diagnosis Of placenta praevia percreta by magnetic Verluskunde en Gynaecologie, Ikazia Ziekenhuis,
resonance imaging. Obstet Gynecol, 80, 506-508. Rotterdam, [Risk of recurrence of retained
9. Kirkinen, P., Helin Martikanien, N. L., Vannined, placental Article in Dutch PMID: 7589748
R., & Partanen, K. (1998). Placenta accreta; (PubMed-lndexe for MEDLIN) 17: Ned Tijdschr
imagine by gray and resonance imaging, J Cilin Geneeskd, 138(43), 2149-2152.
Ultrasound, 26, 90-94. 24. Tandberg, A., Albrechtsen, S., & Iversen, O.
10. Donald. (1992). Retained placenta; In Practical (1999). Manual removal of the placenta, Incidence
Obstetric Problems, 5th edition B I Publications and clinical significance. Acta obstetricia et
(PVT) Ltd, New Delhi, 790-79. gynecologica Scandinavica, 78(1), 33-36.
11. Hayman, R. G. (2007). Retained placenta; In 25. Carroli, G., & Bergel, E. (2004). Umbilical vein
Baskett, T. F., Calder, A. A., Arulkumaran, S. injection for the management of retained placenta
(editor): Munro Kerr's operative obstetrics, 11 th (Cochrane review). In: The Cochrane library, issue
edition, Sydney, Toronto, 237-241. 2, 2004. Chichester, UK: John Wiley and Sons Ltd
12. Hyder, Z. (1995). Retained placenta. Medical (emedicine. Medscape.com/ article/ 275304-
Journal, 2(1), 18-21. overview).
© 2022 |Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 461